AGTXAgentixAGTX info
$0.09info0.00%24h
Global rank35140
Market cap$3.61M
Change 7d233.33%
YTD Performance190.32%
SP500 benchmarkOutperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Agentix (AGTX) Stock Overview

    Agentix Corp., a clinical development stage company, focuses on the development and commercialization of novel therapeutics to treat metabolic diseases. Its product pipeline includes AGTX-2004, a peripherally-acting CB1 receptor antagonist that has demonstrated efficacy in animal models of obesity and type 2 diabetes mellitus; and AGTX-2003, a peripherally-acting CB1 receptor inverse agonist, which has demonstrated efficacy in animal models of obesity and non-alcoholic fatty liver diseases. The company was formerly known as FairWind Energy, Inc. and changed its name to Agentix Corp. in June 2019. Agentix Corp. was founded in 2020 and is based in Dana Point, California.

    AGTX Stock Information

    Symbol
    AGTX
    Address
    32932 Pacific Coast HighwayDana Point, CA 92629United States
    Founded
    -
    Trading hours
    -
    Website
    https://www.agentixcorp.com
    Country
    πŸ‡ΊπŸ‡Έ United States
    Phone Number
    321 299 2014

    Agentix (AGTX) Price Chart

    -
    Value:-

    Agentix Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $0.09
    N/A
    Market Cap
    $3.61M
    N/A
    Shares Outstanding
    40.07M
    N/A
    Employees
    0
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    Β© 2024 Topstocks.org